Search Result

Results for "

(VI)

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Glycoprotein VI (4) Akt (2) Antibiotic (3) Apoptosis (4) Bacterial (3) Biochemical Assay Reagents (5) Carbonic Anhydrase (2) Caspase (2) ClpP (1) COMT (2) COX (1) Drug Intermediate (1) EGFR (1) Endogenous Metabolite (4) HIF/HIF Prolyl-Hydroxylase (2) Influenza Virus (2) IRAK (1) Isotope-Labeled Compounds (2) Mitochondrial Metabolism (1) MMP (1) Na+/K+ ATPase (1) p38 MAPK (3) PERK (2) PGC-1α (1) Phospholipase (1) Pim (1) PPAR (2) Prostaglandin Receptor (2) Proteasome (1) Pyroptosis (2) Reference Standards (5) Src (1) Syk (4)
By Research Areas:	Cancer (12) Cardiovascular Disease (8) Infection (6) Inflammation/Immunology (8) Metabolic Disease (3) Neurological Disease (7)

By Targets:

Glycoprotein VI (4)

Akt (2)

Antibiotic (3)

Apoptosis (4)

Bacterial (3)

Biochemical Assay Reagents (5)

Carbonic Anhydrase (2)

Caspase (2)

ClpP (1)

COMT (2)

COX (1)

Drug Intermediate (1)

EGFR (1)

Endogenous Metabolite (4)

HIF/HIF Prolyl-Hydroxylase (2)

Influenza Virus (2)

IRAK (1)

Isotope-Labeled Compounds (2)

Mitochondrial Metabolism (1)

MMP (1)

Na+/K+ ATPase (1)

p38 MAPK (3)

PERK (2)

PGC-1α (1)

Phospholipase (1)

Pim (1)

PPAR (2)

Prostaglandin Receptor (2)

Proteasome (1)

Pyroptosis (2)

Reference Standards (5)

Src (1)

Syk (4)

By Research Areas:

Cancer (12)

Cardiovascular Disease (8)

Infection (6)

Inflammation/Immunology (8)

Metabolic Disease (3)

Neurological Disease (7)

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

Peptides

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Targets Recommended: Glycoprotein VI

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-18623

VI 16832	Syk Src	Cancer
VI 16832 is a broad spectrum Type I kinase inhibitor which can be used as an enrichment tool for the comparative expression analysis of protein kinases in different cancer cell lines.

HY-N7438

Mogroside VI A	Others	Others
Mogroside VI A, an isomer of Mogroside VI isolated from Luo Han Guo, exerts sweetness property. Mogroside VI A can be used for sweetener and/or taste modifier research .

HY-E70005I

Collagenase, Type VI Type VI collagenase	MMP	Cancer
Collagenase, Type VI (EC 3.4.24.3) is a collagenase that can degrade type VI collagen. Type VI collagen is a component of cell membranes in various tissues (such as skin, heart, blood vessels, cartilage, and synovial fluid). Excessive collagenase can cause extracellular matrix lesions. Collagenase is also a biomarker for tumor invasion and metastasis. Collagenase, Type VI can specifically act on the peptide bond between proline and glycine. This feature can be used to quickly and sensitively detect its concentration level in experiments using corresponding modified electrodes .

HY-N0265

Asperosaponin VI 2 Publications Verification	Caspase Apoptosis PERK p38 MAPK Akt HIF/HIF Prolyl-Hydroxylase PPAR	Cardiovascular Disease Neurological Disease
Asperosaponin VI is a saponin component from Dipsacus asper. Asperosaponin VI induces osteoblast differentiation through the BMP-2/p38 and ERK1/2 signaling pathways. Asperosaponin VI protects against hypoxia-induced cardiomyocyte apoptosis by activating the PI3K/Akt and CREB pathways. Additionally, Asperosaponin VI also has antidepressant and wound-healing-promoting activities .

HY-162228

VI-60	COX Phospholipase	Inflammation/Immunology
VI-60 is a dual, orally active inhibitor of cPLA₂ and COX-2, which reveals an anti-inflammtory efficacy through the inhibition of p38 MAPK/cPLA₂/COX-2/PGE₂ pathway .

HY-N14203

Maridomycin VI	Antibiotic Bacterial	Infection
Maridomycin VI is a macrolide antibiotic. Maridomycin VI has the activity against Gram-positive bacteria and mycoplasma. Maridomycin VI has the effect of protecting Gram-positive bacterial infection mice .

HY-N7527

Baccatin VI	Others	Neurological Disease
Baccatin VI is a natural taxoid with antinociceptive activities. Baccatin VI possesses significant antinociceptive activity against p-Benzoquinone-induced abdominal contractions .

HY-N0265R

Asperosaponin VI (Standard)	Reference Standards Caspase Apoptosis PERK Akt p38 MAPK HIF/HIF Prolyl-Hydroxylase PPAR	Cardiovascular Disease Neurological Disease
Asperosaponin VI (Standard) is the analytical standard of Asperosaponin VI. This product is intended for research and analytical applications. Asperosaponin VI is a saponin component from Dipsacus asper. Asperosaponin VI induces osteoblast differentiation through the BMP-2/p38 and ERK1/2 signaling pathways. Asperosaponin VI protects against hypoxia-induced cardiomyocyte apoptosis by activating the PI3K/Akt and CREB pathways. Additionally, Asperosaponin VI also has antidepressant and wound-healing-promoting activities .

HY-N13146

Azukisaponin VI	Others	Cardiovascular Disease
Azukisaponin VI is an oligosaccharide isolated from Vigna angularis. Azukisaponin VI has the activity of inhibiting the synthesis of lipid peroxides and can be used in the study of hyperlipidemia .

HY-N0816R

Polyphyllin VI (Standard)	Reference Standards Apoptosis Pyroptosis	Cancer
Polyphyllin VI (Standard) is the analytical standard of Polyphyllin VI. This product is intended for research and analytical applications. Polyphyllin VI, an active saponin, possess anti-cancer activities. Polyphyllin VI induces G2/M cell cycle arrest and triggers apoptosis. Polyphyllin VI induces caspase-1-mediated pyroptosis via the induction of ROS/NF-κB/NLRP3/GSDMD signal axis in non-small cell lung cancer .

HY-N5050

OJV-VI	Others	Others
OJV-VI is found in ophiopogonis .

HY-D1435

Oxonol VI	Na+/K+ ATPase	Neurological Disease
Oxonol VI acts as an optical indicator for membrane potentials in lipid vesicles. Oxonol VI is suitable for detecting changes of membrane potential associated with the activity of the (Na ⁺ + K ⁺)-ATPase in reconstituted vesicles .

HY-137119

(±)5-iPF2α-VI 5-iso Prostaglandin F2α-VI	Prostaglandin Receptor	Others
(±)5-iPF2α-VI (5-iso Prostaglandin F2α-VI) is the racemate of 5-iPF2α-VI. 5-iPF2α-VI is a regioisomeric isoprostane formed from arachidonic acid (AA) and is a biomarker of oxidative stress .

HY-N0816

Polyphyllin VI Maximum Cited Publications 6 Publications Verification	Apoptosis Pyroptosis	Cancer
Polyphyllin VI, an active saponin, possess anti-cancer activities. Polyphyllin VI induces G2/M cell cycle arrest and triggers apoptosis. Polyphyllin VI induces caspase-1-mediated pyroptosis via the induction of ROS/NF-κB/NLRP3/GSDMD signal axis in non-small cell lung cancer .

HY-118933

Calpain Inhibitor VI 1 Publications Verification SJA6017	Proteasome	Others
Calpain Inhibitor VI (SJA6017) is a synthesized peptide aldehyde inhibitor of calpain. Calpain Inhibitor VI inhibits purified m-calpain with the IC₅₀ of 80 nM. Calpain Inhibitor VI can be used for the research of cataract .

HY-N7439

Mogroside VI B	PGC-1α	Metabolic Disease
Mogroside VI B, a cucurbitane glucoside, separated from the crude extract of Siraitia grosvenorii. Mogroside VI B shows effect on activating PGC-1α transcription .

HY-N6577

Astragaloside VI	EGFR	Neurological Disease Inflammation/Immunology
Astragaloside VI could activate EGFR/ERK signalling pathway to improve wound healing.

HY-N7306

Jatrophane VI	Others	Others
Jatrophane VI is a Diterpenoids product that can be isolated from the herbs of Euphorbia peplus .

HY-155254

Sodium ionophore VI	Biochemical Assay Reagents	Others
Sodium ionophore VI is a sodium ionophore that has been employed for developing cation optical sensors .

HY-Y0994A

Potassium osmate(VI) dihydrate,99%	Biochemical Assay Reagents	Others
Potassium osmate(VI) dihydrate,99% is a biological molecule.

HY-108275

Mogroside VI	Biochemical Assay Reagents	Metabolic Disease Cancer
Mogroside VI is a triterpenoid glycoside and a nonsugar sweetener. Mogrosides are sweeter than sucrose. Mogrosides exhibit antioxidant, antidiabetic and anticancer activities .

HY-N15355

Jujubasaponin VI	Others	Others
Jujubasaponin VI is a triterpenoid saponin compound found in Zizyphi Fructus, exhibiting anti-ulcer activity. Animal studies have shown that it can significantly inhibit the formation of stress-induced gastric ulcers, possibly through mechanisms such as protecting the gastric mucosa and suppressing gastric acid secretion. Jujubasaponin VI can be used in research related to digestive system diseases, particularly in the areas of gastric ulcers and gastric mucosal injury .

HY-120981S

(±)5-iPF2α-VI-d11	Isotope-Labeled Compounds	Others
(±)5-iPF2α-VI-d₁₁ is the deuterium labeled (±)5-iPF2α-VI .

HY-137119A

8,12-iso-iPF2α-VI	Prostaglandin Receptor	Others
8,12-iso-iPF2α-VI is a F2-isoprostanes. 8,12-iso-iPF2α-VI is a sensitive and specific marker of in vivo lipid peroxidation. 8,12-iso-iPF2α-VI can be used as a biomarker of oxidative damage in alzheimer's disease .

HY-137119AS

8,12-iso-iPF2α-VI-d11	Isotope-Labeled Compounds	Others
8,12-iso-iPF2α-VI-d₁₁ is the deuterium labeled 8,12-iso-iPF2α-VI .

HY-N3991

14β-Benzoyloxy-2-deacetylbaccatin VI	Others	Others
14β-Benzoyloxy-2-deacetylbaccatin VI is a xetane-ring-containing taxoid compound isolated from the leaves and stems of Taxus chinensis .

HY-E70057

alpha-2,8-Sialyltransferase (CstII) ST8Sia VI; GD3 synthase	Endogenous Metabolite	Metabolic Disease
alpha-2,8-Sialyltransferase (CstII) (ST8Sia VI) is a member of alpha2,8-sialyltransferase (ST8Sia) family, is often used in biochemical studies. alpha-2,8-Sialyltransferase (CstII) catalyzes elongation of the α2,8-linked oligo/polysialic acid chain on the Sia residue transferred .

HY-N14505

Mycinamicin Ⅵ	Antibiotic Bacterial	Infection
Mycinamicin VI is a macrolide antibiotic. Mycinamicin VI shows activity against Gram-positive bacteria .

HY-143231

IRAK4-IN-8	IRAK	Infection
IRAK4-IN-8 (VI-177) is a potent IRAK4 inhibitor .

HY-12485R

TBA-354 (Standard)	Reference Standards Bacterial Antibiotic	Infection
Polyphyllin VI (Standard) is the analytical standard of Polyphyllin VI. This product is intended for research and analytical applications. Polyphyllin VI, an active saponin, possess anti-cancer activities. Polyphyllin VI induces G2/M cell cycle arrest and triggers apoptosis. Polyphyllin VI induces caspase-1-mediated pyroptosis via the induction of ROS/NF-κB/NLRP3/GSDMD signal axis in non-small cell lung cancer .

HY-49073

p38 MAP Kinase Inhibitor Ⅵ	p38 MAPK	Cancer
p38 MAP Kinase Inhibitor VI (compound c32) is a p38 MAPK inhibitor with an inhibition rate of 24% .

HY-W100942

Fmoc-D-2-Me-Trp-OH	Biochemical Assay Reagents	Others
Fmoc-D-2-Me-Trp-OH (compound VI) is a polypeptide that can be used as a biochemical assay reagent .

HY-N0260

Epmedin C 5 Publications Verification Epimedin-C; Baohuoside-VI	Others	Inflammation/Immunology
Epmedin C, a natural product, has estrogen-like effects for ovariectomized mice.

HY-115912

GPVI antagonist 3	Glycoprotein VI	Cardiovascular Disease
GPVI antagonist 3 (Compound 2) is a potential antagonist of Glycoprotein VI (GPVI). IC₅₀ values of GPVI antagonist 3 are, respectively, 1.01 μM for collagen, 1.92 μM for CRP, 7.24 μM for convulxin and 51.74 μM for thrombin. Glycoprotein VI (GPVI) is a platelet major collagen receptor and a target for potent and safe antithrombotic research. GPVI antagonist 3 is a promising antiplatelet agent .

HY-115911

GPVI antagonist 2	Glycoprotein VI	Cardiovascular Disease
GPVI antagonist 2 (Compound 1) is a potential antagonist of Glycoprotein VI (GPVI). IC₅₀ values of GPVI antagonist 2 are, respectively, 0.35 μM for collagen, 0.80 μM for CRP, 195.2 μM for convulxin and 81.38 μM for thrombin. Glycoprotein VI (GPVI) is a platelet major collagen receptor and a target for potent and safe antithrombotic research. GPVI antagonist 2 is a promising antiplatelet agent .

HY-143755

Cap-dependent endonuclease-IN-9	Influenza Virus	Infection
Cap-dependent endonuclease-IN-9 is a potent inhibitor of cap-dependent endonuclease (CEN). Not only can Cap-dependent endonuclease-IN-9 inhibit influenza virus well, but also has lower cytotoxicity, better in vivo agent kinetic properties and in vivo pharmacodynamic properties. Cap-dependent endonuclease-IN-9 has strong inhibitory effect on RNA polymerase activity of A virus (extracted from patent CN112521386A, compound VI-1) .

HY-143744

Cap-dependent endonuclease-IN-3	Influenza Virus	Infection
Cap-dependent endonuclease-IN-3 is a potent inhibitor of cap-dependent endonuclease (CEN). Not only can Cap-dependent endonuclease-IN-3 inhibit influenza virus well, but also has lower cytotoxicity, better in vivo agent kinetic properties and in vivo pharmacodynamic properties. Cap-dependent endonuclease-IN-3 has the potential for the research of influenza A and influenza B infection (extracted from patent WO2019141179A1, compound VI-1) .

HY-Y0319D

Acetic acid lead	Endogenous Metabolite	Others
Acetic acid lead can provide either acetate radicals or acetoxonium ions. Acetic acid lead may be an acceptable oxidising agent for the preparation of sulphur (VI) systems, as witnessed by its reaction with thiodithiazyl dichloride .

HY-101947

SMI-16a 5 Publications Verification PIM1/2 Kinase Inhibitor VI	Pim	Cancer
SMI-16a is a selective Pim kinase inhibitor with IC₅₀ values of 0.15, 0.02 and 48 μM for Pim1, Pim2 and PC3 cells, respectively.

HY-N0260R

Epmedin C (Standard) Epimedin-C (Standard); Baohuoside-VI (Standard)	Reference Standards Others	Inflammation/Immunology
Epmedin C (Standard) is the analytical standard of Epmedin C. This product is intended for research and analytical applications.

HY-115998

Carbonic anhydrase inhibitor 11	Carbonic Anhydrase	Cancer
Carbonic anhydrase inhibitor 11 (compound VI) is a potent, selective carbonic anhydrase inhibitor. Carbonic anhydrase inhibitor 11 shows K_i values of 40, 39, 200 and 900 nM against CA II, IX, and XII, respectively .

HY-144390

(S)-S007-1558 1 Publications Verification GPVI antagonist 1	Glycoprotein VI	Cardiovascular Disease
(S)-S007-1558 (compound 5) is a glycoprotein VI (GPVI) platelet receptor antagonist. (S)-S007-1558 inhibits collagen-induced platelet aggregation with an IC₅₀ of 25.3 μM .

HY-100959

3,5-Dinitrocatechol OR-486; 3,5-Dinitropyrocatechol	COMT	Neurological Disease
3,5-Dinitrocatechol (OR-486) is a potent catechol-O-methyltransferase inhibitor, with an IC₅₀ of 12 nM. 3,5-Dinitrocatechol can be used in the preparation of the molybdenum (VI)- 3,5-Dinitrocatechol complex .

HY-133716

Pantoprazole N-oxide	Drug Intermediate	Inflammation/Immunology
Pantoprazole N-oxide (Impurity-VI) is the impurity found during the Pantoprazole (HY-17507) production. Pantoprazole is an inhibitor for proton pump (PPI) that can be used for diseases related to excessive gastric acid, such as gastric ulcers and gastroesophageal reflux disease (GERD) .

HY-P10949

pep-10L peptide	Glycoprotein VI	Cardiovascular Disease
Pep-10L peptide is a glycoprotein VI (GPVI) antagonist with K_i values of 180, 225, and 179 μM for CPR, GPO-1, and Type 1 collagen, respectively. Pep-10L peptide has anti-thrombotic effects .

HY-116083

13,14-Dihydro-15-keto-tetranor prostaglandin D2	Endogenous Metabolite	Others
13,14-Dihydro-15-keto-tetranor prostaglandin D2 (Compound VI) is a prostaglandin D2 metabolite. 13,14-Dihydro-15-keto-tetranor prostaglandin D2 as a biomarker can be used to study prostaglandin D2-related diseases .

HY-109091

Lanraplenib 2 Publications Verification GS-9876	Syk	Inflammation/Immunology Cancer
Lanraplenib (GS-9876) is a highly selective and orally active SYK inhibitor (IC₅₀=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib (GS-9876) inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans .

HY-100959R

3,5-Dinitrocatechol (Standard) OR-486 (Standard); 3,5-Dinitropyrocatechol (Standard)	COMT Reference Standards	Neurological Disease
3,5-Dinitrocatechol (Standard) is the analytical standard of 3,5-Dinitrocatechol. This product is intended for research and analytical applications. 3,5-Dinitrocatechol (OR-486) is a potent catechol-O-methyltransferase inhibitor, with an IC50 of 12 nM. 3,5-Dinitrocatechol can be used in the preparation of the molybdenum (VI)- 3,5-Dinitrocatechol complex .

HY-109091B

Lanraplenib succinate 2 Publications Verification GS-9876 succinate	Syk	Inflammation/Immunology Cancer
Lanraplenib succinate (GS-9876 succinate) is a highly selective and orally active SYK inhibitor (IC₅₀=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib succinate (GS-9876 succinate) inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans .

HY-109091A

Lanraplenib monosuccinate GS-9876 monosuccinate	Syk	Inflammation/Immunology Cancer
Lanraplenib monosuccinate (GS-9876 monosuccinate) is a highly selective and orally active SYK inhibitor (IC₅₀=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib monosuccinate (GS-9876 monosuccinate) inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans .

Cat. No.	Product Name	Type

HY-D1435

Oxonol VI	Fluorescent Dyes/Probes
Oxonol VI acts as an optical indicator for membrane potentials in lipid vesicles. Oxonol VI is suitable for detecting changes of membrane potential associated with the activity of the (Na ⁺ + K ⁺)-ATPase in reconstituted vesicles .

Cat. No.	Product Name	Type

HY-W009022

Diantipyrylmethane	Indicators
Diantipyrylmethane is a chromogenic agent commonly used in spectrophotometry and extraction photometry for the determination of metals such as Au(III), Ti(IV), Ir, Fe(III), Mo, Nd, U(IV), Ir, Pt, and Re. Diantipyrylmethane is a kind of biological materials or organic compounds that are widely used in life science research .

HY-Y0319D

Acetic acid lead	Biochemical Assay Reagents
Acetic acid lead can provide either acetate radicals or acetoxonium ions. Acetic acid lead may be an acceptable oxidising agent for the preparation of sulphur (VI) systems, as witnessed by its reaction with thiodithiazyl dichloride .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N7438

Mogroside VI A	Triterpenes Classification of Application Fields Terpenoids Source classification Other Diseases Cucurbitaceae Siraitia grosvenorii (Swingle) C. Jeffrey ex Lu et Z. Y. Zhang Plants Disease Research Fields Sweeteners Food Research	Others
Mogroside VI A, an isomer of Mogroside VI isolated from Luo Han Guo, exerts sweetness property. Mogroside VI A can be used for sweetener and/or taste modifier research .

HY-N0265

Asperosaponin VI 2 Publications Verification	Cardiovascular Disease Triterpenes Structural Classification Classification of Application Fields Terpenoids Dipsacaceae Source classification Dipsacus asper Plants Disease Research Fields	Caspase Apoptosis PERK p38 MAPK Akt HIF/HIF Prolyl-Hydroxylase PPAR
Asperosaponin VI is a saponin component from Dipsacus asper. Asperosaponin VI induces osteoblast differentiation through the BMP-2/p38 and ERK1/2 signaling pathways. Asperosaponin VI protects against hypoxia-induced cardiomyocyte apoptosis by activating the PI3K/Akt and CREB pathways. Additionally, Asperosaponin VI also has antidepressant and wound-healing-promoting activities .

HY-N0816

Polyphyllin VI Maximum Cited Publications 6 Publications Verification	Structural Classification other families Classification of Application Fields Source classification Plants Disease Research Fields Steroids Cancer	Apoptosis Pyroptosis
Polyphyllin VI, an active saponin, possess anti-cancer activities. Polyphyllin VI induces G2/M cell cycle arrest and triggers apoptosis. Polyphyllin VI induces caspase-1-mediated pyroptosis via the induction of ROS/NF-κB/NLRP3/GSDMD signal axis in non-small cell lung cancer .

HY-N7439

Mogroside VI B	Triterpenes Structural Classification Classification of Application Fields Terpenoids Source classification Cucurbitaceae Metabolic Disease Siraitia grosvenorii (Swingle) C. Jeffrey ex Lu et Z. Y. Zhang Plants Disease Research Fields	PGC-1α
Mogroside VI B, a cucurbitane glucoside, separated from the crude extract of Siraitia grosvenorii. Mogroside VI B shows effect on activating PGC-1α transcription .

HY-N14203

Maridomycin VI	Structural Classification Microorganisms Macrolide Antibiotics Antibiotics Source classification	Antibiotic Bacterial
Maridomycin VI is a macrolide antibiotic. Maridomycin VI has the activity against Gram-positive bacteria and mycoplasma. Maridomycin VI has the effect of protecting Gram-positive bacterial infection mice .

HY-N7527

Baccatin VI	Structural Classification Natural Products Neurological Disease Classification of Application Fields Gibberellins Source classification Taxaceae Phytohormone Plants Disease Research Fields Taxus baccata L. Agricultural Research	Others
Baccatin VI is a natural taxoid with antinociceptive activities. Baccatin VI possesses significant antinociceptive activity against p-Benzoquinone-induced abdominal contractions .

HY-N0265R

Asperosaponin VI (Standard)	Triterpenes Structural Classification Terpenoids Dipsacaceae Source classification Dipsacus asper Plants	Reference Standards Caspase Apoptosis PERK Akt p38 MAPK HIF/HIF Prolyl-Hydroxylase PPAR
Asperosaponin VI (Standard) is the analytical standard of Asperosaponin VI. This product is intended for research and analytical applications. Asperosaponin VI is a saponin component from Dipsacus asper. Asperosaponin VI induces osteoblast differentiation through the BMP-2/p38 and ERK1/2 signaling pathways. Asperosaponin VI protects against hypoxia-induced cardiomyocyte apoptosis by activating the PI3K/Akt and CREB pathways. Additionally, Asperosaponin VI also has antidepressant and wound-healing-promoting activities .

HY-N13146

Azukisaponin VI	Structural Classification Polysaccharides Leguminosae Source classification Vigna angularis (Willd.) Ohwi et Ohashi Plants Saccharides	Others
Azukisaponin VI is an oligosaccharide isolated from Vigna angularis. Azukisaponin VI has the activity of inhibiting the synthesis of lipid peroxides and can be used in the study of hyperlipidemia .

HY-N0816R

Polyphyllin VI (Standard)	Structural Classification other families Source classification Plants Steroids	Reference Standards Apoptosis Pyroptosis
Polyphyllin VI (Standard) is the analytical standard of Polyphyllin VI. This product is intended for research and analytical applications. Polyphyllin VI, an active saponin, possess anti-cancer activities. Polyphyllin VI induces G2/M cell cycle arrest and triggers apoptosis. Polyphyllin VI induces caspase-1-mediated pyroptosis via the induction of ROS/NF-κB/NLRP3/GSDMD signal axis in non-small cell lung cancer .

HY-N5050

OJV-VI	Ophiopogon japonicus (L. f.) Ker-Gawl. Liliaceae Classification of Application Fields Source classification Other Diseases Plants Disease Research Fields Steroids	Others
OJV-VI is found in ophiopogonis .

HY-N6577

Astragaloside VI	Triterpenes Structural Classification other families Leguminosae Terpenoids Source classification Astragalus membranaceus var. mongholicus (Bunge)P.K.Hsiao Plants	EGFR
Astragaloside VI could activate EGFR/ERK signalling pathway to improve wound healing.

HY-N7306

Jatrophane VI	Structural Classification Terpenoids Source classification Euphorbia peplus Linn. Diterpenoids Euphorbiaceae Plants	Others
Jatrophane VI is a Diterpenoids product that can be isolated from the herbs of Euphorbia peplus .

HY-108275

Mogroside VI	Triterpenes Structural Classification Classification of Application Fields Terpenoids Source classification Cucurbitaceae Metabolic Disease Siraitia grosvenorii (Swingle) C. Jeffrey ex Lu et Z. Y. Zhang Plants Disease Research Fields Sweeteners Food Research	Biochemical Assay Reagents
Mogroside VI is a triterpenoid glycoside and a nonsugar sweetener. Mogrosides are sweeter than sucrose. Mogrosides exhibit antioxidant, antidiabetic and anticancer activities .

HY-N15355

Jujubasaponin VI	Structural Classification Polysaccharides Ziziphus jujuba Source classification Plants Rhamnaceae Saccharides	Others
Jujubasaponin VI is a triterpenoid saponin compound found in Zizyphi Fructus, exhibiting anti-ulcer activity. Animal studies have shown that it can significantly inhibit the formation of stress-induced gastric ulcers, possibly through mechanisms such as protecting the gastric mucosa and suppressing gastric acid secretion. Jujubasaponin VI can be used in research related to digestive system diseases, particularly in the areas of gastric ulcers and gastric mucosal injury .

HY-N14505

Mycinamicin Ⅵ	Structural Classification Microorganisms Macrolide Antibiotics Antibiotics Source classification	Antibiotic Bacterial
Mycinamicin VI is a macrolide antibiotic. Mycinamicin VI shows activity against Gram-positive bacteria .

HY-N0260

Epmedin C 5 Publications Verification Epimedin-C; Baohuoside-VI	Flavonols Flavonoids Monophenols Classification of Application Fields Source classification Phenols Epimedium brevicornu Maxim. Plants Berberidaceae Disease Research Fields Inflammation/Immunology	Others
Epmedin C, a natural product, has estrogen-like effects for ovariectomized mice.

HY-Y0319D

Acetic acid lead	Structural Classification Classification of Application Fields Ketones, Aldehydes, Acids Source classification Other Diseases Endogenous metabolite Disease Research Fields	Endogenous Metabolite
Acetic acid lead can provide either acetate radicals or acetoxonium ions. Acetic acid lead may be an acceptable oxidising agent for the preparation of sulphur (VI) systems, as witnessed by its reaction with thiodithiazyl dichloride .

HY-N0260R

Epmedin C (Standard) Epimedin-C (Standard); Baohuoside-VI (Standard)	Flavonols Structural Classification Monophenols Flavonoids Source classification Phenols Epimedium brevicornu Maxim. Plants Berberidaceae	Reference Standards Others
Epmedin C (Standard) is the analytical standard of Epmedin C. This product is intended for research and analytical applications.

Species:	Human (5) Mouse (1)
Tag:	His (4) Tag Free (1)
Source:	HEK293 (4) sf9 insect cells (1) E. coli (1)

Cat. No.	Compare	Product Name	Species	Source

HY-P74533A

	Synaptotagmin VI Protein, Human (N-His) Synaptotagmin-6; Synaptotagmin VI; SytVI; SYT6	Human	E. coli
	The Ptk7 protein is a receptor involved in multiple cellular processes, including cell proliferation and migration. It plays a crucial role in regulating embryonic development and tissue homeostasis. Synaptotagmin VI Protein, Human (N-His) is the recombinant human-derived Synaptotagmin VI protein, expressed by E. coli , with N-His labeled tag.

HY-P70180

	GPVI Protein, Mouse (HEK293, His) 1 Publications Verification rMuGlycoprotein 6 (Platelet)/GPVI, His ; Glycoprotein 6; glycoprotein VI (platelet); GP6; GPIV; GPVI; GPVIplatelet collagen receptor; MGC138168; platelet glycoprotein VI	Mouse	HEK293
	GPVI Protein is a platelet membrane protein with a molecular weight of ~62 kDa that is a physiological collagen receptor. GPVI is present as a complex with the homodimeric Fc receptor y-chain. GPVI must form such a dimeric complex to exhibit high affinity binding to collagen. The GPVI-induced activation mechanism is initiated by tyrosine phosphorylation of the immunoreceptor tyrosine-based activation motif (ITAM) of the FcR gamma-chain, and then this signal is transduced to many related proteins, mainly by tyrosine phosphorylation. Interaction of platelets with collagen via the receptor GPVI results in platelet activation and adhesion. GPVI Protein, Mouse (HEK293, His) is the recombinant mouse-derived GPVI protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P75685

	COL6A3 Protein, Human (HEK293, His) Collagen alpha-3(VI) chain; COL6A3	Human	HEK293
	COL6A3 protein is an important component of type VI collagen and has the function of a cell-binding protein. Collagen VI trimers are composed of three distinct chains: alpha-1(VI), alpha-2(VI), and alpha-3(VI), alpha-5(VI), or alpha-6(VI). COL6A3 Protein, Human (HEK293, His) is the recombinant human-derived COL6A3 protein, expressed by HEK293 , with N-His labeled tag.

HY-P71146

	PRDX5/Peroxiredoxin-5 Protein, Human (HEK293, His) Peroxiredoxin-5; PRDX5; Alu corepressor 1; Antioxidant enzyme B166; AOEB166; Liver tissue 2D-page spot 71B; PLP; Peroxiredoxin V; Prx-V; Peroxisomal antioxidant enzyme; TPx type VI; Thioredoxin peroxidase PMP20; Thioredoxin reductase	Human	HEK293
	The PRDX5 protein (or Peroxiredoxin-5) plays a critical role as a thiol-specific peroxidase that reduces hydrogen peroxide and organic hydroperoxides. This enzyme activity is essential for cells to defend against oxidative stress and detoxify peroxides. PRDX5/Peroxiredoxin-5 Protein, Human (HEK293, His) is the recombinant human-derived PRDX5/Peroxiredoxin-5 protein, expressed by HEK293 , with N-6*His labeled tag.

HY-P75684

	COL6A3 Protein, Human (HEK293) Collagen alpha-3(VI) chain; COL6A3	Human	HEK293
	COL6A3 protein is an important component of type VI collagen and has the function of a cell-binding protein. Collagen VI trimers are composed of three distinct chains: alpha-1(VI), alpha-2(VI), and alpha-3(VI), alpha-5(VI), or alpha-6(VI). COL6A3 Protein, Human (HEK293) is the recombinant human-derived COL6A3 protein, expressed by HEK293 , with tag free.

HY-P704835

	PAD6 Protein, Human (sf9, His) PADI6; PREMBL2; Peptidylarginine Deiminase VI; Peptidylarginine Deiminase Type 6	Human	sf9 insect cells
	PAD6 Protein, Human (sf9, His) is the recombinant human-derived PAD6 protein, expressed by sf9 insect cells, with N-His tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-120981S

(±)5-iPF2α-VI-d11
(±)5-iPF2α-VI-d₁₁ is the deuterium labeled (±)5-iPF2α-VI .

HY-137119AS

8,12-iso-iPF2α-VI-d11
8,12-iso-iPF2α-VI-d₁₁ is the deuterium labeled 8,12-iso-iPF2α-VI .

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P82892

	Collagen VI alpha 1/2/3 Antibody (YA2637) Alpha 1 (VI) chain (61 AA); COL6A1; COL6A2; COL6A3; Collagen alpha 2(VI) chain; Collagen alpha 3(VI) chain; OPLL; PP3610	WB, IHC-P, ICC/IF	Human, Mouse, Rat
	Collagen VI alpha 1/2/3 Antibody (YA2637) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2637), targeting Collagen VI alpha 1/2/3, with a predicted molecular weight of 109 kDa (observed band size: 147 kDa). Collagen VI alpha 1/2/3 Antibody (YA2637) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.

HY-P80945

	Annexin VI Antibody (YA618) p68; p70; ANX6; CBP68; CPB-II	WB, IHC-P, IP	Human, Mouse, Rat
	Annexin VI Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 76 kDa, targeting to Annexin A6 (ANXA6). It can be used for WB,IHC-P,IP assays in the background of Human, Mouse, Rat.

HY-P81048

	Collagen VI Antibody (YA893) Alpha 1 (VI) chain (61 AA) antibody; CO6A1_HUMAN antibody; COL6A1 antibody; Collagen alpha-1(VI) chain antibody; Collagen type VI alpha 1 antibody; Collagen VI alpha 1 polypeptide antibody; Collagen VI antibody; Human mRNA for collagen VI alpha 2 C terminal globular domain antibody; OPLL antibody; PP3610 antibody	WB, ICC/IF, IHC-P	Human, Mouse, Rat
	Collagen VI Antibody (YA893) is an unconjugated, approximately 109 kDa, rabbit-derived, anti-Collagen VI (YA893) monoclonal antibody. Collagen VI Antibody (YA893) can be used for: WB, IF-Cell, IF-Tissue, IHC-P expriments in human, mouse, rat background without labeling.

HY-P85575

	Annexin VI Antibody (YA5267) 67 kDa calelectrin; Annexin A6; Annexin VI; Annexin VI p68; Annexin-6; AnnexinA6; AnnexinVI; ANX 6; ANX A6; ANX6; ANXA6; ANXA6_HUMAN; Calcium binding protein p68; Calelectrin; Calphobindin II; Calphobindin-II; CalphobindinII; CBP 68; Chromobindin 20; CPBII; Lipocortin VI; LipocortinVI; Protein III; ProteinIII.	WB	Human
	Annexin VI Antibody (YA5267) is a mouse-derived and non-conjugated monoclonal antibody, targeting to Annexin VI. It can be applicated for WB assays, in the background of human.

HY-P82788

	Collagen VI alpha 1 Antibody (YA2533) OPLL; BTHLM1; UCHMD1	WB, IHC-F, IHC-P, ICC/IF	Human
	Collagen VI alpha 1 Antibody (YA2533) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2533), targeting Collagen VI alpha 1, with a predicted molecular weight of 109 kDa (observed band size: 147 kDa). Collagen VI alpha 1 Antibody (YA2533) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.

HY-P86911

	Human Kappa light chain Antibody (YA6604) Immunoglobulin kappa variable 1D-16 Ig kappa chain V-I region HK146 Ig kappa chain V-I region HK189 Immunoglobulin kappa constant Ig kappa chain C regionCurated Ig kappa chain C region AG Ig kappa chain C region CUM Ig kappa chain C region EU Ig kappa chain C region OU Ig kappa chain C region ROY Immunoglobulin kappa variable 1D-16 Ig kappa chain V-I region HK146 Ig kappa chain V-I region HK189 Immunoglobulin kappa constant Ig kappa chain C regionCurated Ig kappa chain C region AG Ig kappa chain C region CUM Ig kappa chain C region EU Ig kappa chain C region OU Ig kappa chain C region ROY Ig kappa chain C region TI	WB, IHC-P	Human

HY-P85498

	IL-8 Antibody (YA5190) Ala-IL-8; 77; Ser-IL-8; 72; 3 10C; 310C; AMCF 1; AMCF1; b ENAP; Bbeta thromboglobulin like protein; Beta thromboglobulin like protein; C-X-C motif chemokine 8; CXC chemokine ligand 8; CXCL 8; CXCL8; Emoctakin; GCP 1; GCP-1; GCP/IL-8 protein I; GCP/IL-8 protein II; GCP/IL-8 protein III; GCP/IL-8 protein IV; GCP/IL-8 protein V; GCP/IL-8 protein VI; GCP1; Granulocyte chemotactic protein 1; IL 8; IL-8; IL-8; 1-77; IL-8; 9-77; IL8; IL8/NAP1 form I; IL8/NAP1 form II; IL8/NAP1 form III; IL8/NAP1 form IV; IL8/NAP1 form V; IL8/NAP1 form VI; IL8_HUMAN; Inteleukin 8; Interleukin8; K 60; K60; LECT; LUCT; Lymphocyte derived neutrophil activating factor; Lymphocyte-derived neutrophil-activating factor; LYNAP; MDNCF; MDNCF-b; MDNCF-c; MONAP; Monocyte derived neutrophil activating peptide; Monocyte derived neutrophil activating protein; Monocyte derived neutrophil chemotactic factor; Monocyte-derived neutrophil chemotactic factor; Monocyte-derived neutrophil-activating peptide; NAF; NAP 1; NAP-1; NAP1; Neutrophil activating factor; Neutrophil activating peptide 1; Neutrophil activating protein 1; Neutrophil-activating factor; Neutrophil-activating protein 1; Protein 3 10C; Protein 3-10C; SCYB 8; SCYB8; Small inducible cytokine subfamily B member 8; T cell chemotactic factor; T-cell chemotactic factor; TSG 1; TSG1;	WB, ELISA	Human
	IL-8 Antibody (YA5190) is a mouse-derived and non-conjugated monoclonal antibody, targeting to IL-8. It can be applicated for WB, ELISA assays, in the background of human.

HY-P86889

	GNAS Antibody (YA6582) Adenylate cyclase stimulating G alpha protein antibody; AHO antibody; Alternative gene product encoded by XL exon antibody; C20orf45 antibody; dJ309F20.1.1 antibody; dJ806M20.3.3 antibody; Extra large alphas protein antibody; GNAS antibody; GNAS complex locus antibody; GNAS1 antibody; Adenylate cyclase stimulating G alpha protein antibody; AHO antibody; Alternative gene product encoded by XL exon antibody; C20orf45 antibody; dJ309F20.1.1 antibody; dJ806M20.3.3 antibody; Extra large alphas protein antibody; GNAS antibody; GNAS complex locus antibody; GNAS1 antibody; GPSA antibody; Gs alpha subunit antibody; GSA antibody; GSP antibody; Guanine nucleotide binding protein (G protein) alpha stimulating activity polypeptide 1 antibody; Guanine nucleotide binding protein alpha stimulating activity polypeptide 1 antibody; Guanine nucleotide binding protein G(s) subunit alpha isoforms short antibody; Guanine nucleotide binding protein G(s) subunit alpha isoforms XLas antibody; Guanine nucleotide regulatory protein antibody; MGC33735 antibody; NESP antibody; NESP55 antibody; Neuroendocrine secretory protein antibody; PHP1A antibody; PHP1B antibody; PHP1C antibody; POH antibody; Protein ALEX antibody; Protein GNAS antibody; Protein NESP55 antibody; SCG6 antibody; Secretogranin VI antibody; XLalphas antibody; XLas antibody	WB, ICC/IF, IHC-P	Human, Mouse, Rat

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

(VI)

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

Peptides

NaturalProducts

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Natural
Products